Return to search

Primmune Therapeutics scores $7m seed

San Diego-based Primmune Therapeutics, a developer of immunotherapies for cancer and acute viral diseases, has raised $7 million in seed financing.

San Diego-based Primmune Therapeutics, a developer of immunotherapies for cancer and acute viral diseases, has raised $7 million in seed financing. The investors were CAM Capital, Charlie McDermott, BioBrit and BioRock Ventures.

Source: Press Release